-355.1 -5.0% Gross Profit 707.7 1,026.1 -318.4 -31.0% Gross Profit Margin (%) 9.5% 12.6% -3.1% SG&A expenses 459.9 440.4 19.5 4.4% Loss on exchange rate 0.0 35.4 -35.4 -100.0% EBIT before share of profit
% Administrative Expenses (42.8) (37.5) 14.3% (118.6) (82.4) 44.0% Finance Costs (84.4) (84.2) 0.3% (245.5) (282.7) -13.2% Share of Profit from Investments in Associates and Joint Ventures 418.5 547.3 -23.5% 1,510.4
580.1 562.9 3.1% Other Income4 145.7 162.7 -10.5% Administrative Expenses (197.5) (130.8) 51.0% Finance Costs (342.0) (366.6) -6.7% Share of Profit from Investments in Associates and Joint Ventures
580.1 562.9 3.1% Other Income4 145.7 162.7 -10.5% Administrative Expenses (197.5) (130.8) 51.0% Finance Costs (342.0) (366.6) -6.7% Share of Profit from Investments in Associates and Joint Ventures
performance of the listed companies. Whereas in the second quarter 2019, The Company had gain on sale of equity securities. The Company recognized share of profit from associates of Baht 24.06 million in this
6,380.3 -499.7 -7.8 Gross Profit 555.9 772.3 -216.5 -28.0 Gross Profit Margin (%) 8.6 10.8 -2.2 SG&A expenses 455.9 428.5 27.4 6.4 EBIT before share of profit (loss) from investment in associates and joint
shares to the shareholders of the Company at the offering price of Baht 56 per share. As a result, the company has a total ordinary shares of 2,819,729,367 shares and have changed the paid-up capital to a
expenses 42 46 (4) -9% Administrative expenses 23 29 (6) -18% Profit for the year 2 (11) 13 115% Profit (loss) attributable to Equity holders of the Company 2 (11) 13 115% Earnings per share (THB/share) 0.00
months recorded a sharp increase by 573% from the same period of last year which was directly affected by a decrease in shares of loss and a lower of total expenses. Net Profit (Loss): EASON reported a net
selling price due to limited export from China. The overall sales volume decreased, except for ECH, as a consequence of major turnaround in Q2’ 18. The share of domestic and export sales have no significant